MWNA
ELGX

Marshall Wace North America’s Endologix Inc ELGX Stock Holding History

Marshall Wace North America’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-14,334
Closed -$57K – 1764
2019
Q3 		$57K Sell
14,334
-95,607
-87% -$556K ﹤0.01% 1149
2019
Q2 		$796K Buy
+109,941
New +$750K ﹤0.01% 804
2017
Q3 		– Sell
-17,394
Closed -$870K – 1651
2017
Q2 		$870K Buy
17,394
+12,784
+277% +$753K 0.01% 969
2017
Q1 		$323K Buy
+4,610
New +$305K ﹤0.01% 859

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Marshall Wace North America's ELGX Position: Q4 2019 in Review

Marshall Wace North America sold out of Endologix Inc (ELGX) in Q4 2019, closing a stake of 14,334 shares — an estimated $57K sold.

Marshall Wace North America first reported a position in ELGX in Q1 2017 and held it in 4 quarters. The position peaked at $870K in Q2 2017. 57 funds tracked by Wall St. Rank hold ELGX as of Q4 2019.

  • Marshall Wace North America reported no remaining Endologix Inc position as of Q4 2019 after selling out during the quarter.
  • Marshall Wace North America sold 14,334 Endologix Inc shares in Q4 2019, an estimated $57K.
  • Marshall Wace North America first reported a position in Endologix Inc in Q1 2017 and held it in 4 quarters.
  • Marshall Wace North America's Endologix Inc position peaked at $870K in Q2 2017.
  • 57 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2019.

Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.